Additionally, changes in dietary intake that often accompany these medicationssuch as reduced fat consumption or altered meal timingcan independently affect bowel patterns
References in the comments-- #Pharmacy #Hypertension #FutureOfMedicine #ClinicalTrials #Biotech #RNAi #Cardiology #HealthcareInnovation To view or add a comment, sign in In episode 12 of Wicked Good Cardiometabolic Chat, powered by Drug Topics, pharmacy and diabetes experts Jennifer D Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, and Hailey Choi, PharmD, BCACP, CDCES, break down the most impactful diabetes technology updates emerging from the 2026 American Diabetes Association (ADA) Scientific Sessions
Tissue remodeling peptide vs Coenzyme (not a peptide)
GLP-1 and the cardiovascular system
Hessmann, E., Johnsen, S